Narrowband UV-B, monochromatic excimer laser, and photodynamic therapy in psoriasis: A consensus statement of the spanish psoriasis group

J. M. Carrascosa, J. L. López-Estebaranz, G. Carretero, E. Daudén, C. Ferrándiz, D. Vidal, I. Belinchón, M. Sánchez-Regaña, L. Puig

Research output: Contribution to journalArticleResearchpeer-review

16 Citations (Scopus)

Abstract

Novel treatment strategies and new information concerning the management of moderate to severe psoriasis justify a reassessment of the role of the classic therapies in this setting. This consensus statement evaluates narrowband UV-B therapy, which is currently considered the phototherapy option of choice in psoriasis because of its risk-to-benefit ratio. The role of excimer laser and photodynamic therapies are also discussed. These targeted therapies are still only available in a small number of centers in Spain and are used principally in the treatment of localized and recalcitrant forms of psoriasis. We discuss the efficacy and safety of phototherapy as well as treatment regimens, combination therapy, and clinical considerations relating to the characteristics of the patient or the disease. © 2010 Elsevier España, S.L. and AEDV. All rights reserved.
Original languageEnglish
Pages (from-to)175-186
JournalActas Dermo-Sifiliograficas
Volume102
Issue number3
DOIs
Publication statusPublished - 1 Jan 2011

Keywords

  • Excimer laser
  • Narrowband UV-B
  • Photodynamic therapy
  • Phototherapy
  • Psoriasis

Fingerprint Dive into the research topics of 'Narrowband UV-B, monochromatic excimer laser, and photodynamic therapy in psoriasis: A consensus statement of the spanish psoriasis group'. Together they form a unique fingerprint.

Cite this